|
Market Closed -
Toronto S.E.
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 10.01 CAD | -0.30% |
|
+5.70% | +65.45% |
| 09-02 | Knight Therapeutics Gets Regulatory Approval for TAVALISSE in Colombia | MT |
| 09-01 | Knight Therapeutics Announces Regulatory Approval of Tavalisse in Colombia | CI |
| Market Cap | 983M 711M 612M 575M 526M 67.1B 986M 6.8B 2.64B 34.43B 2.67B 2.61B 111B | P/E 2026 * |
72.4x | P/E 2027 * | 37.6x |
|---|---|---|---|---|---|
| Enterprise Value | 983M 711M 612M 575M 526M 67.1B 986M 6.8B 2.64B 34.43B 2.67B 2.61B 111B | EV / Sales 2026 * |
1.78x | EV / Sales 2027 * | 1.79x |
| Free-Float |
53.01% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GUD | Delayed | |
OTC Markets
| KHTRF | Delayed | |
|
Deutsche Boerse AG
| 04K | Delayed | |
|
Tradegate
| 04K | Real-time | |
|
Boerse Muenchen
| 04K | Real-time | |
|
Börse Stuttgart
| 04K | Delayed |
Last Transcript : Knight Therapeutics Inc.
| 1 day | -0.30% | ||
| 1 week | +5.70% | ||
| Current month | +3.62% | ||
| 1 month | +5.37% | ||
| 3 months | +16.26% | ||
| 6 months | +62.50% | ||
| Current year | +65.45% |
| 1 week | 9.56 |  | 10.1 |
| 1 month | 9.2 | | 10.1 |
| Current year | 5.66 | | 10.17 |
| 1 year | 5.66 | | 10.17 |
| 3 years | 4.35 | | 10.17 |
| 5 years | 4.28 | | 10.17 |
| 10 years | 4.28 | | 11.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 57 | 2021-08-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 2020-03-29 |
Melanie Groleau
CTO | Chief Tech/Sci/R&D Officer | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Goodman
CHM | Chairman | 58 | 2021-08-31 |
James Gale
CHM | Chairman | 77 | - |
Robert Lande
BRD | Director/Board Member | 63 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/13/26 | Option | Chief Financial Officer | -45,054 | 0.0459% | ||
| 7/13/26 | Option | Chief Financial Officer | 8,066 | 0.0082% | ||
| 6/10/26 | Option | Chief Technology Officer | -4,390 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | +5.70% | +55.43% | +126.47% | 711M | |
| -1.32% | +1.33% | +77.46% | +41.17% | 371B | |
| -0.63% | -2.84% | +21.72% | -19.35% | 68.64B | |
| -0.51% | +4.59% | +47.06% | +168.63% | 12.51B | |
| -0.56% | -9.06% | -8.11% | -8.78% | 8.06B | |
| +0.23% | -1.59% | -20.70% | +6.13% | 5.04B | |
| 0.00% | -4.12% | -31.60% | +20.55% | 4.51B | |
| -0.35% | -3.11% | -33.77% | +1.20% | 3.07B | |
| -1.00% | -0.46% | -5.37% | +37.45% | 2.53B | |
| -0.50% | -3.98% | -24.35% | -16.61% | 2B | |
| Average | -0.49% | -1.00% | +7.78% | +35.68% | 47.8B | |
| Weighted average by Cap. | -1.15% | +0.48% | +63.54% | +34.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 552M 399M 344M 323M 295M 37.7B 554M 3.82B 1.48B 19.34B 1.5B 1.47B 62.31B | 549M 397M 342M 321M 294M 37.47B 551M 3.8B 1.47B 19.23B 1.49B 1.46B 61.94B |
| Net income | 13.32M 9.63M 8.28M 7.79M 7.12M 909M 13.35M 92.09M 35.74M 466M 36.15M 35.36M 1.5B | 26.36M 19.06M 16.4M 15.43M 14.09M 1.8B 26.44M 182M 70.74M 923M 71.56M 70M 2.97B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | $10.01 | -0.30% | 44,902 |
| 26-09-03 | $10.04 | +3.83% | 488,532 |
| 26-09-02 | $9.670 | +0.31% | 86,258 |
| 26-09-01 | $9.640 | -0.21% | 35,761 |
| 26-08-31 | $9.660 | +2.01% | 55,797 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GUD Stock
Select your edition
All financial news and data tailored to specific country editions
